| 05.06 14:33 | dpa-AFX: Waters Corp. To Present At The Jefferies 2024 Healthcare Conference; Webcast At 9:30 AM ET |
| 04.06 12:08 | ÖBAG verkauft Vamed-Beteiligung an Fresenius |
| 07.05 13:02 | dpa-AFX: Waters Corp. Q1 24 Earnings Conference Call At 8:00 AM ET |
| 07.05 12:58 | dpa-AFX: Waters Corp. Q1 Profit Decreases, but beats estimates |
| 07.05 12:53 | dpa-AFX: *WATERS CORP EXPECTS Q2 ORGANIC CONSTANT CURRENCY SALES GROWTH TO BE IN THE RANGE OF -6.0% TO -4.0% |
| 07.05 12:53 | dpa-AFX: *WATERS CORP EXPECTS Q2 NON-GAAP EPS TO BE IN RANGE OF $2.50 TO $2.60 |
| 07.05 12:52 | dpa-AFX: *WATERS CORP Q1 SALES DOWN 7% TO $637 MLN |
| 07.05 12:51 | dpa-AFX: *WATERS CORP MAINTAINS FY VIEW AT -0.5% TO +1.5% ORGANIC CC SALES GROWTH AND NON-GAAP EPS OF $11.75 TO $12.05 |
| 07.05 12:51 | dpa-AFX: *WATERS CORP Q1 GAAP EPS $1.72; NON-GAAP EPS $2.21 |
| 06.02 12:54 | dpa-AFX: Waters Corp. Q4 Profit Decreases, but beats estimates |
| 06.02 12:53 | dpa-AFX: *WATERS CORP Q4 NET INCOME $216.2 MLN VS $227.1 MLN LAST YEAR |
| 06.02 12:53 | dpa-AFX: *WATERS CORP SEES Q1 NON-GAAP EPS OF $2.05 TO $2.15 |
| 06.02 12:53 | dpa-AFX: *WATERS CORP EXPECTS Q1 ORGANIC CONSTANT CURRENCY SALES GROWTH TO BE IN RANGE OF -11% TO -9% |
| 06.02 12:52 | dpa-AFX: *WATERS CORP Q4 SALES $819 MLN, DOWN 4.5% AS REPORTED AND 8% IN ORGANIC CONSTANT CURRENCY |
| 06.02 12:52 | dpa-AFX: *WATERS CORP Q4 NON-GAAP EPS $3.62; GAAP EPS $3.65 |
| 06.12 12:32 | dpa-AFX: *WATERS CORP OPENS NEW STATE-OF-THE-ART GLOBAL CAPABILITY CENTER IN BENGALURU, INDIA |
| 07.11 13:24 | dpa-AFX: ROUNDUP: Waters Sees Q4 Earnings Below Market; Cuts FY23 Outlook |
| 07.11 13:00 | dpa-AFX: Waters Corp. Q3 23 Earnings Conference Call At 8:00 AM ET |
| 07.11 12:56 | dpa-AFX: Waters Corp. Q3 Profit Decreases, but beats estimates |
| 07.11 12:55 | dpa-AFX: *WATERS CORP EXPECTS Q4 ORGANIC CONSTANT CURRENCY SALES GROWTH TO DECLINE IN RANGE OF -8% TO -5% |
|
|
